Feasibility, safety, and impact of the RTS,S/AS01<sub>E</sub> malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
在國家免疫計畫中實施 RTS,S/AS01<sub>E</sub> 疟疾疫苗的可行性、安全性和影響:對加納、肯亞和馬拉威引入該疫苗的集群隨機評估。
Lancet 2024-04-07
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial.
甘比亞麻疹與風疹疫苗微針貼片:一項第1/2期、雙盲、雙安慰劑、隨機、積極對照、年齡逐步降低的試驗。
Lancet 2024-05-02
Effect of a spatial repellent on malaria incidence in an area of western Kenya characterised by high malaria transmission, insecticide resistance, and universal coverage of insecticide treated nets (part of the AEGIS Consortium): a cluster-randomised, controlled trial.
在肯尼亞西部一個特徵為高瘧疾傳播、昆蟲icide抗藥性及普遍使用殺蟲劑處理網的地區,空間驅避劑對瘧疾發病率的影響(AEGIS Consortium的一部分):一項集群隨機對照試驗。
Lancet 2024-12-22
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial.
在馬利,9個月和15個月時與常規兒童疫苗共同接種的針對 A、C、W、Y 和 X 血清型的五價腦膜炎球菌結合疫苗的安全性和免疫原性:一項單中心、雙盲、隨機、對照的第三期非劣效性試驗。
Lancet 2025-03-14
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial.
美國青少年和成人中 Chikungunya 病毒類似顆粒疫苗的安全性和免疫原性:一項第三期、隨機、雙盲、安慰劑對照試驗。
Lancet 2025-03-30